Small molecule anti-malarial patents: a review (January 2010 – June 2011)

Bibliography

• World malaria report, 2010, WHO. Available from: http://www.who.int/malaria/world_malaria_report_2010/en/index.html
   Google Scholar
• Wells TNC, Alonso PL, Gutteridge WE. New medicines to improve control and contribute to the eradication of malaria. Nat Drug Discov Rev 2009;8:879-91
   PubMed Web of Science ®Google Scholar
• Available from: http://www.reuters.com/article/2011/01/14/us-malaria-vaccine-gsk-idUSTRE70D25L20110114
   Google Scholar
• Alonso PL, Brown G, Arevalo-Herrera M, 2011 A research agenda to underpin malaria eradication. PLoS Med 2011;8(1):e1000406
   PubMed Web of Science ®Google Scholar
• Available from: http://www.mmv.org/research-development/science-portfolio
   Google Scholar
• Available from: http://www.mmv.org/newsroom/publications/mmv-annual-report-2010
   Google Scholar
• Plouffe D, Brinker A, McNamara C, In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci USA 2008;105:9059-64
   PubMed Web of Science ®Google Scholar
• Guiguemd WA, Shelat AA, Bouck D., Chemical genetics of Plasmodium falciparum. Nature 2010;465:311-15
   PubMed Web of Science ®Google Scholar
• Gamo F-J, Sanz LM, Vidal J., Thousands of chemical starting points for antimalarial lead identification. Nature 2010;465:305-10
   PubMed Web of Science ®Google Scholar
• Posner GH. D’Angelo J, O’Neill PM, Mercer A. Anticancer activity of artemisinin-derived trioxanes. Expert Opin Ther Patents 2006;12:1665-72
   Google Scholar
• Mital A. Recent advances in antimalarial compounds and their patents. Curr Med Chem 2007;14:759-73
   PubMed Web of Science ®Google Scholar
• Monzote L. A review of antiparasitic patents (1988 – 2008). Recent Pat Antiinfect Drug Discov 2008;3:177-91
   PubMedGoogle Scholar
• Gemma S, Travagli V, Savini L, Malaria chemotherapy. Recent Pat Antiinfect Drug Discov 2010;5:195-225
   PubMedGoogle Scholar
• Seven Indian patents published in English in 2010 – 2011 were not readily obtainable and hence excluded from this review
   Google Scholar
• The Searete patents were excluded from this analysis
   Google Scholar
• Muraleedharan KM, Avery MA. Progress in the development of peroxide-based anti-parasitic agents. Drug Discov Today 2009;14:793-803
   PubMed Web of Science ®Google Scholar
• Krishna S, Bustamante L, Haynes RK, Artemisinins: their growing importance in medicine. Trends Pharmacol Sci 2008;29:520-7
   PubMed Web of Science ®Google Scholar
• Ding XC, Beck H-P, Raso G. Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets. Trends in Parasit 2011;27:73-81
   PubMed Web of Science ®Google Scholar
• The Johns Hopkins University. Preparation of trioxane monomer and dimer derivatives for use in the treatment of malaria and cancer. WO135427; 2010
   Google Scholar
• The Johns Hopkins University. Preparation of trioxane dimer sulfur compounds useful in the treatment of cancer and malaria. WO009428; 2010
   Google Scholar
• North-West University. Preparation of prodrugs of artemisinin as antimalarials. WO032165; 2010
   Google Scholar
• Lombard MC, N’Da DN, Breytenbach JC, Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids. Bioorg Med Chem Lett 2011;21:1683-6
   PubMed Web of Science ®Google Scholar
• Liverpool School of Tropical Medicine. Preparation of dispirocyclohexanyltetraoxanylcycloalkylphenol derivatives and analogs for use as antimalarials. WO109172; 2010
   Google Scholar
• The Regents of the University of California. Fluorescent spiroadamantane-1,2,4-trioxolane derivatives as parasite cysteine protease inhibitors and their preparation, pharmaceutical compositions and use in the treatment of parasitic diseases and cancers. WO011684; 2010
   Google Scholar
• The U.S. Army Medical Research and Material Command. Pentafluorosulfanyl analogs of mefloquine. WO144102; 2010
   Google Scholar
• The U.S. Army Medical Research and Material Command. Next generation quinoloine methanols. WO144101; 2010
   Google Scholar
• The U.S. Army Medical Research and Material Command. Derivatives of mefloquine and associated methods for making and using. WO144434; 2010
   Google Scholar
• Milner E, McCalmont W, Bhonsle J, Anti-malarial activity of a non-piperidine library of next generation quinoline methanols Malaria J. 2010;9:51
   Google Scholar
• Designmedix, Inc., Portland State University. Modified chloroquines with single ring moiety or fused ring moiety, their preparation and use for treating malaria. WO065932; 2010
   Google Scholar
• Designmedix, Inc., Portland State University. Modified chloroquines with branched moiety. WO065925; 2010
   Google Scholar
• Oregon Health & Science University, U.S. Department of Veterans Affairs. Aminoquinoline derivatives as antimalarial agents and their preparation, pharmaceutical compositions and their use in the treatment of parasitic diseases. WO059633; 2010
   Google Scholar
• University of Cape Town. Preparation of quinoline compounds for treating malaria. WO018555; 2010
   Google Scholar
• Actelion Pharmaceuticals. Novel bis-amides as antimalarial agents and their preparation and use in the treatment of protozoal infections. WO058353; 2010
   Google Scholar
• Universita' Degli Studi Di Firenze, Istituto Superiore Di Sanita'. Preparation of 3-azabicyclo3.2.1.octane derivatives as peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases. WO060904; 2010
   Google Scholar
• Universita' Degli Studi Di Firenze, Istituto Superiore Di Sanita'. Preparation of 3-azabicyclo3.2.1.octane derivatives as peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases. EP2189462; 2010
   Google Scholar
• CSIR. Triazine derivatives for use in the treatment of malaria and their preparation. WO018742; 2011
   Google Scholar
• Board of Regents University of Texas system, Monash University, Medicines for Malaria Venture. 1,2,4-Triazolo[1,5-a]pyrimidine derivatives as dihydroorotate dehydrogenase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of malaria. WO041304; 2011
   Google Scholar
• Board of Trustees of the University of Illinois. Preparation of alkynyl diphosphates as Enzyme inhibiting compounds and methods. WO044505; 2011
   Google Scholar
• Andrews KT, Tran TN, Wheatley NC, Fairlie DP. Targeting histone deacetylase inhibitors for anti-malarial therapy. Curr Top Med Chem 2009;9:292-308
   PubMed Web of Science ®Google Scholar
• Georgia Tech Research Corp. Preparation of descladinose-clarithromycin-azithromycin non-peptide macrocyclic histone deacetylase (HDAC) inhibitors. US0197622; 2010
   Google Scholar
• Sigma Tau Industrie Farmaceutiche Riunite S.p.A. Non-natural macrocyclic amides as HDAC6 inhibitors and their preparation and use in the treatment of diseases. WO047326; 2011
   Google Scholar
• Elixir Pharmaceuticals, Inc. Compounds, compositions, and methods for treating malaria or leishmaniasis. WO054382; 2010
   Google Scholar
• CNRS, Technische Universitat Carlowilhelmina Zu Braunchschweig. Preparation of new derivatives of thieno[2,3-b]pyridine and 5,6,7,8-tetrahydrothieno[2,3-b]quinoline useful in the treatment of malaria. WO042860; 2011
   Google Scholar
• CNRS. Preparation of new derivatives of thieno[2,3-b]pyridine and 5,6,7,8-tetrahydrothieno[2,3-b]quinoline useful in the treatment of malaria. EP2308883; 2011
   Google Scholar
• IRM LLC. Imidazopyrazinamine compounds as antimalarial agents and their preparation, compositions and use for the treatment of parasitic diseases. WO006143; 2011
   Google Scholar
• Glaxo Group Ltd. Preparation of 4(1H)-pyridinone derivatives as antimalarial agents. EP2246329; 2010
   Google Scholar
• Glaxo Group Ltd. Preparation of 4(1H)-pyridinone derivatives as antimalarial agents. WO081904; 2010
   Google Scholar
• Glaxo Group Ltd. Preparation of 3-(2-phenylpyridin-5-yl)-4(1H)-pyridinone derivatives for use as antimalarial agents. WO142741; 2010
   Google Scholar
• Yeates CL, Batchelor JF, Capon EC, Synthesis and structure–activity relationships of 4-pyridones as potential antimalarials. J Med Chem 2008;5:2845-52
   Google Scholar
• Oregon Health & Science University, U.S. Department of Veterans Affairs. Preparation of naphthoquinones, acridones, quinolones, pyridones, anthraquinones, and xanthones as parasiticides. US7829578; 2010
   Google Scholar
• Department of Health and Human Services as representative of the United States of America. Inhibitors of the plasmodial surface anion channel as antimalarials. WO011537; 2010
   Google Scholar
• Eisai R&D Management Co., Ltd. Benzoxazole derivatives as toll-like receptor antagonists and their preparation, pharmaceutical compositions and use in the treatment of malaria. WO036908; 2010
   Google Scholar
• Lexicon Pharmaceuticals, Inc. S1P receptor agonists for the treatment of cerebral malaria. WO051349; 2010
   Google Scholar
• Lexicon Pharmaceuticals, Inc. Preparation of sphingosine-1-phosphate (S1P) lyase inhibitors for the treatment of cerebral malaria. US051353; 2010
   Google Scholar
• Rheinische Friedrich-Wilhelms-Universtat Bonn. Pharmaceutical composition containing cannabinoid-receptor antagonists. WO045068; 2011
   Google Scholar
• Rheinische Friedrich-Wilhelms-Universtat Bonn. Pharmaceutical composition containing cannabinoid-receptor 2 antagonists. EU2311443; 2011
   Google Scholar
• Universita di Pisa. N-Hydroxyazole derivatives as lactate dehydrogenase inhibitors and their preparation and use for the treatment of diseases. WO054525; 2011
   Google Scholar
• Emory University. Triarylmethane analogs and their use in treating cancers and other diseases. US0189762; 2010
   Google Scholar
• Emory University. Use of imipramine blue and analogs in treating cancers and parasitic infections. WO0160296; 2010
   Google Scholar
• Cempra Pharmaceuticals. Methods for treating malaria, tuberculosis and Mycobacterium Avium Complex (MAC) diseases using fluoroketolides. WO032052; 2011
   Google Scholar
• Still JG, Schranz J, Degenhardt TP, Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects. Antimicrob Agents Chemother 2011;55:1997-2003
   PubMed Web of Science ®Google Scholar
• Entarco SA. The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer. WO150100; 2010
   Google Scholar
• Genesis Biopharma, Millenia Hope Biologics. Use of voacamine and related compounds to enhance the activity of existing malaria treatments. CA2655893; 2010
   Google Scholar
• Radix Pharmaceuticals, Inc. Ocimum sanctum natural product derivatives with antimalarial activity. US0087469; 2010
   Google Scholar
• Radix Pharmaceuticals, Inc. Small molecules with antiprotozoal activity. US292264; 2010
   Google Scholar
• Immune Modulation, Inc. Derivatives of hypoestoxide and related compounds for treating malaria. WO056223; 2010
   Google Scholar
• Immune Modulation, Inc. Derivatives of hypoestoxide and related compounds for treating malaria. US0120853; 2010
   Google Scholar
• GSK Istrazivacki Centar Zagreb D.O.O. Preparation of 3'-N-substituted 9-deoxo-9a-methyl-9a-aza-homo-erythromycin A having antimalarial activity. WO086351; 2010
   Google Scholar
• Oregon Health & Science University, U.S. Department of Veterans Affairs. Preparation of quinolines and quinolones having antiparasitic or antiinfectious activity. WO65905; 2010
   Google Scholar
• Genzyme Corp., Harvard, MIT. Preparation of 2-aminoindole compounds for the treatment of malaria. WO053697; 2011
   Google Scholar
• University of Graz. Preparation of 3-azabicyclo3.2.2.nonane derivatives for treatment of malaria and trypanosomiasis. WO035355; 2011
   Google Scholar
• University of Graz. Preparation of 3-azabicyclo3 2.2.nonane derivatives for treatment of malaria and trypanosomiasis. EP2301627; 2011
   Google Scholar
• NIH. Compounds that treat malaria and prevent malaria transmission. WO022327; 2011
   Google Scholar
• Sowunmi A. A randomised comparison of chloroquine and chloroquine plus ketotifen in the treatment of acute, uncomplicated, P. falciparum in children. Ann Trop Med Parasitol 2003;97:103-17
   PubMed Web of Science ®Google Scholar
• Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents. WO025970; 2011
   Google Scholar
• Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents. WO045505; 2010
   Google Scholar
• Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents. WO045503; 2010
   Google Scholar
• Zhang Y-K,, Plattner JJ, Freund YR, Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents. Bioorg Med Chem Lett 2011;21:644-51
   PubMed Web of Science ®Google Scholar
• Available from: http://www.anacor.com/pdf/Malaria_ASTMH_Poster_Final.pdf
   Google Scholar
• 4SC AG. Preparation of sulfamoylphenylureidobenzamidine derivatives for use as antimalarial agents. WO086177; 2010
   Google Scholar
• The U. S. Army Medical Research and Material Command. Imidazolidinedione derivatives as antimalarial agents and their preparation, pharmaceutical compositions and use in the treatment of malaria. WO051129; 2010
   Google Scholar
• University Health Network. Triazolium and imidazolium salts as parasiticides and their preparation, pharmaceutical compositions and use in the treatment of malaria. WO025558; 2010
   Google Scholar
• Polymedix, Inc., The Trustees of the University of Pennsylvania. Preparation of aromatic and heteroaromatic compounds useful in the treatment of malaria. WO014573; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. WO065118; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0135983; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0135984; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0137247; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0137844; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0137246; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0137843; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0135908; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0137787; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0136097; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0136096; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0136095; 2010
   Google Scholar
• Searete LLC. Anti-inflammatory compositions and methods for modulating Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes. US0136094; 2010
   Google Scholar
• Sun S, Rao NL, Venable J, TLR7/9 Antagonists as therapeutics for immune-mediated inflammatory disorders. Inflamm Allerg Drug Targets 2007;6:223-5
   PubMedGoogle Scholar
• Parroche P, Lauw FN, Goutagny N, Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to toll-like receptor 9. Proc Natl Acad Sci USA 2007;104:1219-24
   PubMed Web of Science ®Google Scholar
• Searete LCC. Biological targeting compositions comprising red blood cells and methods of using. US00427072; 2010
   Google Scholar
• Searete LCC. Biological targeting compositions and methods of using the same. US0040546; 2010
   Google Scholar
• Advanced Applied Physics Solutions, Inc. Carbohydrate-metallocene-antimalarial conjugates. WO094130; 2010
   Google Scholar
• University of Greenwich. Preparation of triazine compounds as sodium channel blockers. WO004196; 2011
   Google Scholar
• University of Greenwich. Preparation of 1,2,4-triazine compounds as sodium channel blockers and as antimalarials. GB2471713; 2010
   Google Scholar
• University of Greenwich. Preparation of 1,2,4-triazine compounds as sodium channel blockers and as antimalarials. GB2471729; 2010
   Google Scholar
• Rees RWA, Russell PB, Foell TJ, Bright RE. Antimalarial activity of some 3,5-diamino-as-triazine derivatives. J Med Chem 1972;15:859-61
   PubMed Web of Science ®Google Scholar
• Albert Einstein college of Medicine of Yeshiva University. Transition state structure of orotate phosphoribosyltransferases and its uses to design antimalarial inhibitors. WO068239; 2010
   Google Scholar
• IPCA Labarotories Ltd. Novel atovaquone-proguanil complex for treatment and/or prophylaxis of parasitic infections. WO021230; 2011
   Google Scholar
• Bueno Calderon JM, Chicharro Gonzalo J, Lorenzo Garcia M, Novel heterocyclic compounds. WO2007138048; 2007
   Google Scholar
• Glaxogroup Ltd. Phosphate ester of a 4-pyridone derivative and its use in the chemotherapy of parasitic infections. WO094738; 2010
   Google Scholar
• Citrox Ltd, Kimbolton, Cambridgeshire. Use of flavonoids to treat parasitic infection. EP2198862; 2010
   Google Scholar
• National University of Singapore. Synthesis and use of coumarin fluorophore-tagged antimalarials. WO002415; 2011
   Google Scholar
• Merck Frosst Canada Ltd. Preparation of dipeptide nitriles as papain family cysteine protease inhibitors for the treatment of parasitic diseases. WO148488; 2010
   Google Scholar
• Cenix Bioscience GMBH, Faculdade de Mecidina Da Universidade de Lisboa. Use of inhibitors of host kinases for the treatment of infectious diseases. WO049172; 2010
   Google Scholar
• Universitat de Sao Paolo, USP; Fundacao de Amparo A Pesquira Do Estado de Sao Paolo - FAPESP. Pharmaceutical composition, drug screening method and method for treating malaria. WO037198; 2010
   Google Scholar
• Available from: http://www.gsk.com/collaborations/our-commitment.htm
   Google Scholar
• Available from: http://www.mmv.org/research-development/essential-information-scientists/target-product-profiles
   Google Scholar
• Available from: http://www.mmv.org/research-development/science-portfolio
   Google Scholar
• Burrows JN, Chibale K, Wells TNC. The state of the art in anti-malarial drug discovery and development. Curr Top Med Chem 2011;11:1226-54
   PubMed Web of Science ®Google Scholar
• Wells TNC. Natural products as starting points for future anti-malarial therapies: going back to our roots? Malaria J 2011;10:S3: Available from: http://www.malariajournal.com/content/pdf/1475-2875-10-S1-S3.pdf
   Web of Science ®Google Scholar
• Mboya-Okeyo T, Ridley RG, Nwaka S, The African network for drugs and diagnostics innovation. Lancet 2009;373:1507-8
   PubMed Web of Science ®Google Scholar